Verdinexor (KPT-335) 1392136-43-4 Verdinexor (KPT-335) is an orally bioavailable, selective XPO1/CRM1 inhibitor.

BLZ945 953769-46-5 BLZ945 is an orally active, potent and selective CSF-1R inhibitor with IC50 of 1 nM, 1000-fold selective against its closest receptor tyrosine kinase homologs.

Doxercalciferol 54573-75-0 Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease.

Cerdulatinib (PRT062070, PRT2070) 1369761-01-2 Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM

Cabotegravir 1051375-10-0 Cabotegravir (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor against a broad range of HIV subtypes

Anidulafungin (LY303366) 166663-25-8 Anidulafungin (LY303366), an echinocandin derivative, inhibits glucan synthase activity, used as an antifungal drug.

NVP-AEW541 475489-16-8 NVP-AEW541 is a potent inhibitor of IGF-1R/InsR with IC50 of 150 nM/140 nM, greater potency and selectivity for IGF-1R in a cell-based assay.

URMC-099 1229582-33-5 URMC-099 is an orally bioavailable, brain penetrant mixed lineage kinase (MLK) inhibitor with IC50 of 19 nM, 42 nM, 14 nM